SCHEMBL4002159

SCHEMBL4002159

[Li]C1C([Si](C)(C)C2=Cc3ccccc3C2[Li])=Cc2ccccc21

nearest known ligand 0.32

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 1/20 0.32
CYP11B1 P15538 1/20 0.32
CYP11B2 P19099 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8335287 0.88 CYP19A1 (0.30) CYP19A1CYP11B1CYP11B2
SCHEMBL5603420 0.76 CYP19A1 (0.30) CYP19A1CYP11B1CYP11B2
SCHEMBL7781726 0.72 HTR2A (0.32) CYP19A1CYP11B1CYP11B2
SCHEMBL5090888 0.71 LMNA (0.33) CYP19A1CYP11B1CYP11B2
SCHEMBL5160641 0.71 CDC25A (0.32)
SCHEMBL7642643 0.69 CYP19A1 (0.31) CYP19A1CYP11B1CYP11B2
SCHEMBL27550145 0.69 MAOA (0.38) CYP19A1CYP11B1CYP11B2
Hydrochloric Acid SCHEMBL6813002 0.68 CYP11B1 (0.33) CYP19A1CYP11B1CYP11B2
Benzene SCHEMBL6817712 0.68 LMNA (0.31) CYP19A1CYP11B1CYP11B2
Hydrochloric Acid SCHEMBL7536192 0.68 CYP19A1 (0.30) CYP19A1CYP11B1CYP11B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1556417-B1 RACEMOSELECTIVE PREPARATION OF BRIDGED METALLOCENE COMPLEXES HAVING UNSUBSTITUTED OR 2-SUBSTITUTED INDENYL LIGANDS BASELL POLYOLEFINE GMBH (DE) 2009-06-10 EP disclosed
EP-1554296-B1 RACEMOSELECTIVE PREPARATION OF ISOLABLE ANSA-METALLOCENE BIPHENOXIDE COMPLEXES BASELL POLYOLEFINE GMBH (DE) 2008-10-15 EP disclosed
US-7358381-B2 Racemoselective preparation of bridged metallocene complexes having unsubstituted or 2-substituted indenyl ligands BASELL POLYOLEFINE GMBH (DE) 2008-04-15 US disclosed
US-7193099-B2 Racemoselective preparation of isolable ansa-metallocene biphenoxide complexes BASELL POLYOLEFINE GMBH (DE) 2007-03-20 US disclosed
US-20060111527-A1 Racemoselective preparation of bridged metallocene complexes having unsubstituted or 2-substituted indenyl ligands EQUISTAR CHEMICALS, LP 2006-05-25 US disclosed
US-20060052587-A1 Racemoselective preparation of isolable ansa-metallocene biphenoxide complexes BASELL POLYOLEFINE GMBH (DE) 2006-03-09 US disclosed
EP-0462588-A2 Olefin block copolymer and method of producing same MITSUBISHI PETROCHEMICAL CO., LTD. (JP) 1991-12-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060111527-A1 Racemoselective preparation of bridged metallocene complexes having unsubstituted or 2-substituted indenyl ligands ITPA, IMPA1, INTS9 CYP19A1 982/4885CYP11B1 352/4885CYP11B2 451/4885
US-20060052587-A1 Racemoselective preparation of isolable ansa-metallocene biphenoxide complexes ITPA, NBAS, ARSA CYP19A1 18/4885CYP11B1 142/4885CYP11B2 394/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.